Publication | Open Access
Potent inhibitory effect of a series of modified cyclodextrin sulfates on the replication of HIV-1 in vitro
47
Citations
0
References
1991
Year
ImmunologyAltmetric Attention ScorePharmacotherapyAntiviral DrugMolecular PharmacologyMedicinal ChemistryAntiviral Drug DevelopmentPotent Inhibitory EffectModified Cyclodextrin SulfatesSocial Media PresenceHivDrug DevelopmentPharmacologyAntiviral CompoundCyclodextrin ProductionAntiviral TherapyMedicineDrug DiscoveryQuantitative Pharmacology
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTPotent inhibitory effect of a series of modified cyclodextrin sulfates on the replication of HIV-1 in vitroTamon Moriya, Hironori Kurita, Kazuo Matsumoto, Toru Otake, Haruyo Mori, Motoko Morimoto, Noboru Ueba, and Nobuharu KunitaCite this: J. Med. Chem. 1991, 34, 7, 2301–2304Publication Date (Print):July 1, 1991Publication History Published online1 May 2002Published inissue 1 July 1991https://pubs.acs.org/doi/10.1021/jm00111a055https://doi.org/10.1021/jm00111a055research-articleACS PublicationsRequest reuse permissionsArticle Views222Altmetric-Citations42LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts